Protein-bound uremic toxins as therapeutic targets for cardiovascular, kidney, and metabolic disorders

Area of Science:

• Nephrology
• Cardiology
• Metabolic Diseases

Background:

• Cardiovascular-kidney-metabolic (CKM) syndrome is a complex condition involving interactions between metabolic abnormalities, chronic kidney disease, and cardiovascular diseases.
• This syndrome leads to multi-organ dysfunction and increased cardiovascular events.
• Current management strategies for CKM syndrome risk are insufficient.

Purpose of the Study:

• To explore the intricate interactions among cardiac, renal, and metabolic pathways within the context of uremic toxins.
• To highlight the critical role of uremic toxins as potential therapeutic targets in CKM syndrome pathophysiology.
• To review strategies for regulating uremic toxins for CKM syndrome management.

Main Methods:

• Literature review focusing on the interplay of uremic toxins with cardiovascular, kidney, and metabolic systems.
• Analysis of evidence supporting the role of uremic toxins in CKM syndrome development and progression.
• Exploration of therapeutic strategies targeting uremic toxins.

Main Results:

• Uremic toxins significantly contribute to the pathophysiology of CKM syndrome.
• Addressing uremic toxins and their pathways shows potential in reducing CKM syndrome risk.
• Regulation of uremic toxins may offer avenues for disease reversal and management.

Conclusions:

• Uremic toxins are key players in CKM syndrome and represent viable therapeutic targets.
• Targeting uremic toxins may provide novel approaches for clinical diagnosis and treatment of CKM syndrome.
• Further research into uremic toxin regulation is warranted for effective CKM syndrome management.